| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:430.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Departments of Pathology (F.F., R.M.G.) and Medicine (D.Y.G., R.M.G.), VA Medical Center and Baylor College of Medicine, Houston, Tex; Department of Pathology (A.R.S.), University of Pittsburgh, Pittsburgh, Pa; and Department of Internal Medicine (F.F., A.G., P.P., N.G.S., G.G.), Catholic University of Rome, Italy.
Correspondence to Robert M. Genta, MD, Pathology 113, VAMC, 2002 Holcombe Blvd, Houston, TX 77030. E-mail rmgenta{at}bcm.tmc.edu
Background Helicobacter pylori-CagA positive strains have been shown to be associated with atherosclerosis. However, the pathogenesis is still undetermined. The aim of this study was to determine whether anti-CagA antibodies cross-react with antigens of normal and atherosclerotic arteries.
Methods and Results Eight umbilical cord sections, 14 atherosclerotic artery sections, and 10 gastrointestinal tract sections were examined by immunohistochemistry using polyclonal anti-CagA antibodies. Five atherosclerotic and 3 normal artery samples were also lysed in ice-cold lysis buffer containing protease inhibitors and were immunoprecipitated using the same antibodies. Anti-CagA antibodies reacted with cytoplasm and nuclei of smooth muscle cells in umbilical cord and atherosclerotic vessel sections, cytoplasm of fibroblasts-like cells in intimal atherosclerotic plaques, and the cell membranes of endothelial cells. Anti-CagA antibodies also specifically immunoprecipitated 2 high molecular weight antigens of 160 and 180 kDa from both normal and atherosclerotic artery lysates.
Conclusions Anti-CagA antibodies cross-react with antigens of both normal and atherosclerotic blood vessels. We speculate that the binding of anti-CagA antibodies to those antigens in injured arteries could influence the progression of atherosclerosis in CagA-positive H pylori-infected patients.
Key Words: atherosclerosis infection antibodies
This article has been cited by other articles:
![]() |
F. Megraud and P. Lehours Helicobacter pylori Detection and Antimicrobial Susceptibility Testing Clin. Microbiol. Rev., April 1, 2007; 20(2): 280 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pietroiusti, M. Giuliano, A. Magrini, A. Bergamaschi, and A. Galante Cytotoxin-Associated Gene A Strains of Helicobacter Pylori Represent a Risk Factor for the Development of Microalbuminuria in Type 2 Diabetes. Diabetes Care, June 1, 2006; 29(6): 1399 - 1401. [Full Text] [PDF] |
||||
![]() |
S. C. Sacca, A. Pascotto, G. M. Venturino, G. Prigione, A. Mastromarino, F. Baldi, C. Bilardi, V. Savarino, C. Brusati, and A. Rebora Prevalence and Treatment of Helicobacter pylori in Patients with Blepharitis Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 501 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Espinola-Klein, S. Blankenberg, and T. Munzel Editorial Comment--Is Heme Oxygenase-1 a Causal Player for Plaque Stability? Stroke, September 1, 2005; 36(9): 1901 - 1903. [Full Text] [PDF] |
||||
![]() |
M. Diomedi, A. Pietroiusti, M. Silvestrini, B. Rizzato, L. M. Cupini, F. Ferrante, A. Magrini, A. Bergamaschi, A. Galante, and G. Bernardi CagA-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke Neurology, September 14, 2004; 63(5): 800 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Preusch, A. J. Grau, F. Buggle, C. Lichy, J. Bartel, C. Black, and J. Rudi Association Between Cerebral Ischemia and Cytotoxin-Associated Gene-A-Bearing Strains of Helicobacter pylori Stroke, August 1, 2004; 35(8): 1800 - 1804. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gabrielli, A. Santoliquido, F. Cremonini, V. Cicconi, M. Candelli, M. Serricchio, P. Tondi, R. Pola, G. Gasbarrini, P. Pola, et al. CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke Eur. Heart J., January 1, 2004; 25(1): 64 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T Keller, A. T.A Mairuhu, M. D de Kruif, S. K Klein, V. E.A Gerdes, H. ten Cate, D. P.M Brandjes, M. Levi, and E. C.M van Gorp Infections and endothelial cells Cardiovasc Res, October 15, 2003; 60(1): 40 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lindsberg and A. J. Grau Inflammation and Infections as Risk Factors for Ischemic Stroke Stroke, October 1, 2003; 34(10): 2518 - 2532. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Khairy, S. Rinfret, J.-C. Tardif, R. Marchand, S. Shapiro, J. Brophy, and J. Dupuis Absence of Association Between Infectious Agents and Endothelial Function in Healthy Young Men Circulation, April 22, 2003; 107(15): 1966 - 1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mayr, S. Kiechl, M. A. Mendall, J. Willeit, G. Wick, and Q. Xu Increased Risk of Atherosclerosis Is Confined to CagA-Positive Helicobacter pylori Strains: Prospective Results From the Bruneck Study Stroke, March 1, 2003; 34(3): 610 - 615. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |